Terrie Curran

President and CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

PHAT

CEO, Board Member

5 calls Latest call 2025-03-06

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Phathom Pharmaceuticals, Inc. (PHAT)	Former President and Chief Executive Officer	$184,000	—	$473,472	$1,445,213	—	$2,834,106	$4,936,791
2024	Phathom Pharmaceuticals, Inc. (PHAT)	Former President and Chief Executive Officer	$708,125	—	—	$2,471,283	$368,225	$17,250	$3,564,883
2023	Phathom Pharmaceuticals, Inc. (PHAT)	Former President and Chief Executive Officer	$687,500	—	$1,357,957	$830,538	$518,152	$16,875	$3,411,022
2022	Phathom Pharmaceuticals, Inc. (PHAT)	President and Chief Executive Officer	$650,000	—	—	$3,932,145	$442,358	$15,375	$5,039,878
2021	Phathom Pharmaceuticals, Inc. (PHAT)	President and Chief Executive Officer	$567,500	—	—	$5,294,273	$396,257	$14,625	$6,272,655
2020	Phathom Pharmaceuticals, Inc. (PHAT)	President and Chief Executive Officer	$498,940	—	$483,000	$3,285,608	$356,875	$10,031	$4,634,454
2019	Phathom Pharmaceuticals, Inc. (PHAT)	President and Chief Executive Officer —	$41,667	—	—	$3,394,338	$23,091	—	$3,459,096

Earnings-call appearances and filed executive appointments or departures, newest first.